Professor Neil Hawkins

Professor (Health Economics & Health Technology Assessment)

Biography

Neil holds a PhD in Pharmacology from the University of Bristol, Masters Degrees in Health Economics (York) and Applied Statistics (Sheffield), and also an MBA from the University of Oxford. He has over 17 years experience in the field of HTA and has participated in over thirty health technology assessments covering a wide variety of clinical areas. Previously he was a Reader in Health Technology Assessment (HTA) at the London School of Hygiene and Tropical Medicine, and Vice President leading the global Health Economics practice at ICON plc.

He has published numerous articles in international journals including Health Economics, Medical Decision Making, Heart and Value in Health. In addition he has conducted workshops discussing methods for evidence synthesis and decision analytic modelling in North and South America, Europe, Asia and Saudi Arabia, and also taught on short courses entitled ‘Introduction to Statistics’, ‘Introduction to Systematic Review and Meta-Analysis’ and ‘Development of Conceptual Models’ at meetings of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Research interests

Neil's research focuses on evidence synthesis and decision analytic modelling, precision medicine, and early stage health technology assessment. He also acts as a consultant in HTA to the pharmaceutical and device industries providing both strategic and analytic advice, and has acted as an external consultant on the National Institute of Health and Clinical Excellence (NICE) Scientific Advice programme.

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011

Number of items: 72.

2024

Cherney, D., Folkerts, K., Mernagh, P., Nikodem, M., Pawlitschko, J., Rossing, P. and Hawkins, N. (2024) Comparative efficacy of Finerenone versus Canagliflozin in patients with chronic kidney disease and type 2 diabetes: a matching-adjusted indirect comparison. Journal of Market Access and Health Policy, 12(3), pp. 169-180. (doi: 10.3390/jmahp12030014)

Freeman, S. C., Sutton, A. J., Cooper, N. J., Gasparini, A., Crowther, M. J. and Hawkins, N. (2024) Bayesian pairwise meta‐analysis of time‐to‐event outcomes in the presence of non‐proportional hazards: a simulation study of flexible parametric, piecewise exponential and fractional polynomial models. Research Synthesis Methods, (doi: 10.1002/jrsm.1722) (PMID:38772906)

Bouttell, J. , Fraser, H. , Goodlad, J. R., Hopkins, D. , McKay, P., Oien, K. A. , Seligmann, B., Von Delft, S. and Hawkins, N. (2024) Adding a gene expression profile test to aid differential diagnosis and treatment in aggressive large B-cell lymphoma: an early exploratory economic evaluation. Applied Health Economics and Health Policy, 22(2), pp. 243-254. (doi: 10.1007/s40258-023-00845-1) (PMID:38017318)

Heggie, R., Jaiswal, N. , McCartney, E. , Moss, J., Menne, T., Jones, B., Boyd, K. , Soulis, E., Hawkins, N. and Wu, O. (2024) Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation. Value in Health, 27(1), pp. 7-14. (doi: 10.1016/j.jval.2023.09.2996) (PMID:37844662)

Szabo, S. M., Hawkins, N. S. and Germeni, E. (2024) The extent and quality of qualitative evidence included in health technology assessments: a review of submissions to NICE and CADTH. International Journal of Technology Assessment in Health Care, 40(1), e6. (doi: 10.1017/S0266462323002829) (PMID:38126273) (PMCID:PMC10859830)

2023

Bouttell, J. , Hawkins, N. , Masson, R. and Goodlad, J. (2023) OP79 Gene Expression Profiling In The Diagnosis Of Aggressive Large B Cell Lymphoma: An Early Exploratory Economic Evaluation. HTAi 2023 Annual Meeting, Adelaide, Australia, 24-28 June 2023. S21–S21. (doi: 10.1017/s0266462323000995)

Owusu Achiaw, S. , Hawkins, N. , Wu, O. and Mercer, J. (2023) HTA178 Using Mixed-Methods Development-Focused HTA and Npv Calculations to Guide Further Investment and R&D: A Case Study on Establishing the Value Proposition for Biosensor-Integrated Self-Reporting Arteriovenous Grafts. ISPOR Europe 2023, Copenhagen, Denmark, 11-15 Nov 2023. (doi: 10.1016/j.jval.2023.09.1862)

Deo, S. et al. (2023) Lipid-lowering in ‘very high risk’ patients undergoing coronary artery bypass surgery and its projected reduction in risk for recurrent vascular events: A Monte Carlo stepwise simulation approach. Journal of Cardiovascular Pharmacology, 81(2), pp. 120-128. (doi: 10.1097/FJC.0000000000001374) (PMID:36315474)

Morga, A., Latimer, N. R., Scott, M., Hawkins, N. , Schlichting, M. and Wang, J. (2023) Is intention to treat still the gold standard or should health technology assessment agencies embrace a broader estimands framework?: insights and perspectives from the national institute for health and care excellence and institut für qualität und wirtschaftlichkeit im gesundheitswesen on the international council for harmonisation of technical requirements for pharmaceuticals for human use E9 (R1) addendum. Value in Health, 26(2), pp. 234-242. (doi: 10.1016/j.jval.2022.08.008) (PMID:36150999)

2022

Brady, M. C. et al. (2022) Dosage, intensity, and frequency of language therapy for aphasia: a systematic review–based, individual participant data network meta-analysis. Stroke, 53(3), pp. 956-967. (doi: 10.1161/STROKEAHA.121.035216) (PMID:34847708) (PMCID:PMC8884127)

Hannigan, L. J. , Phillippo, D. M., Hanlon, P. , Moss, L. , Butterly, E. W., Hawkins, N. , Dias, S., Welton, N. J. and McAllister, D. A. (2022) Improving the estimation of subgroup effects for clinical trial participants with multimorbidity by incorporating drug class-level information in Bayesian hierarchical models: a simulation study. Medical Decision Making, 42(2), pp. 228-240. (doi: 10.1177/0272989X211029556) (PMID:34407672) (PMCID:PMC8777306)

Bouttell, J. , Heggie, R., Oien, K. , Romaniuk, A., VanSteenhouse, H., von Delft, S. and Hawkins, N. (2022) Economic evaluation of genomic/genetic tests: a review and future directions. International Journal of Technology Assessment in Health Care, 38(1), e67. (doi: 10.1017/S0266462322000484)

2021

Bouttell, J. and Hawkins, N. (2021) Evaluation of triage tests when existing test capacity is constrained: application to rapid diagnostic testing in COVID-19. Medical Decision Making, 41(8), pp. 978-987. (doi: 10.1177/0272989X211014114) (PMID:34009068) (PMCID:PMC8488642)

Bauersachs, R., Wu, O. , Hawkins, N. , Bowrin, K., Wojciechowski, P., Clay, E. and Huelsebeck, M. (2021) Efficacy and safety of rivaroxaban compared with other therapies used in patients with peripheral artery disease undergoing peripheral revascularization: a systematic literature review and network meta-analysis. Cardiovascular Therapeutics, 2021, 8561350. (doi: 10.1155/2021/8561350) (PMID:34497668) (PMCID:PMC8407972)

Bouttell, J. , Briggs, A. and Hawkins, N. (2021) A toolkit of methods of development-focused health technology assessment. International Journal of Technology Assessment in Health Care, 37(1), e84. (doi: 10.1017/S0266462321000507)

Bouttell, J. , Hawkins, N. and Briggs, A. (2021) The thorny issue of value alignment: how development-focused health technology assessment can help find win–win situations for patients and healthcare systems and commercial investors. International Journal of Technology Assessment in Health Care, 37(1), e57. (doi: 10.1017/S026646232100026X) (PMID:33875040)

2020

Bouttell, J. , Hawkins, N. and Grieve, E. (2020) Maximizing the value of engineering and technology research in healthcare: development‐focused health technology assessment. In: Imran, M. A., Ghannam, R. and Abbasi, Q. H. (eds.) Engineering and Technology for Healthcare. Wiley-IEEE: Hoboken, NJ, pp. 1-27. ISBN 9781119644248 (doi: 10.1002/9781119644316.ch1)

Heggie, R., Chappell, F., Crawford, F., Martin, A., Gupta, S., Hawkins, N. , Horne, M., Leese, G.P. and Lewsey, J. (2020) The complication rate among people with diabetes at low risk of foot ulceration in Fife, UK: an analysis of routinely collected data. Diabetic Medicine, 37(12), pp. 2116-2123. (doi: 10.1111/dme.14339) (PMID:32510602)

Crawford, F. et al. (2020) Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model. Health Technology Assessment, 24(62), (doi: 10.3310/hta24620)

Bouttell, J. , Briggs, A. and Hawkins, N. (2020) A different animal? Identifying the features of health technology assessment for developers of medical technologies. International Journal of Technology Assessment in Health Care, 36(4), pp. 285-291. (doi: 10.1017/S0266462320000380)

Bouttell, J. , Grieve, E. and Hawkins, N. (2020) The role of development-focused health technology assessment in optimizing science, technology, and innovation to achieve sustainable development goal 3. In: Adenle, A. A., Chertow, M. R., Moors, E. H.M. and Pannell, D. J. (eds.) Science, Technology, and Innovation for Sustainable Development Goals: Insights from Agriculture, Health, Environment, and Energy. Oxford University Press: New York, NY. ISBN 9780190949501

Gordon, J. et al. (2020) Estimating the value of new antimicrobials in the context of antimicrobial resistance: development and application of a dynamic disease transmission model. PharmacoEconomics, 38, pp. 857-869. (doi: 10.1007/s40273-020-00906-6) (PMID:32249396)

Wiksten, A., Hawkins, N. , Piepho, H.-P. and Gsteiger, S. (2020) Non-proportional hazards in network meta-analysis: efficient strategies for model building and analysis. Value in Health, 23(7), pp. 918-927. (doi: 10.1016/j.jval.2020.03.010) (PMID:32762994)

Benmassaoud, A. et al. (2020) Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews, 1, CD013123. (doi: 10.1002/14651858.CD013123.pub2) (PMID:31978257)

Komolafe, O. et al. (2020) Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews, 1, CD013125. (doi: 10.1002/14651858.CD013125.pub2) (PMID:31978256)

Brady, M. C. et al. (2020) RELEASE: a protocol for a systematic review based, individual participant data, meta- and network meta-analysis, of complex speech-language therapy interventions for stroke-related aphasia. Aphasiology, 34(2), pp. 137-157. (doi: 10.1080/02687038.2019.1643003)

Heggie, R., Chappell, F., Crawford, F., Green, A., Gupta, S., Hawkins, N. , Horne, M., Leese, G. P. and Lewsey, J. (2020) The complication rate among people with diabetes at low risk of foot ulceration in Fife, UK. An analysis of routinely collected data. EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].

2019

Palmer, D. H., Hawkins, N. S. , Vilgrain, V., Pereira, H., Chatellier, G. and Ross, P. J. (2019) Tumor burden and liver function in HCC patient selection for selective internal radiation therapy: SARAH post-hoc study. Future Oncology, 16(1), pp. 4315-4325. (doi: 10.2217/fon-2019-0658) (PMID:31797680)

Sampson, C. J. et al. (2019) Transparency in decision modelling: What, why, who and how? PharmacoEconomics, 37(11), pp. 1355-1369. (doi: 10.1007/s40273-019-00819-z) (PMID:31240636)

Iogna Prat, L. et al. (2019) Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews, 9, CD013120. (doi: 10.1002/14651858.cd013120.pub2) (PMID:31524949)

Best, L. M.J. et al. (2019) Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews, 9, CD013103. (doi: 10.1002/14651858.cd013103.pub2) (PMID:31513287)

Bouttell, J. , Tan, Y. Y., Creed, D., McGaffin, G., Hawkins, N. , McLaughlin, R., Smith, G., Westwood, P., Williams, N. and Graham, J. (2019) Context-specific economic evaluation for molecular pathology tests: An application in colorectal cancer in the West of Scotland. International Journal of Technology Assessment in Health Care, 35(4), pp. 327-333. (doi: 10.1017/S026646231900045X) (PMID:31292015)

Lozano-Ortega, G., Walker, D., Rogula, B., Deighton, A., Johnston, K., Hawkins, N. and Dmochowski, R. (2019) The relative efficacy and safety of mirabegron and onabotulinumtoxinA in patients with overactive bladder who have previously been managed with an antimuscarinic: A network meta-analysis. Urology, 127, pp. 1-6. (doi: 10.1016/j.urology.2019.02.005) (PMID:30790650)

Bouttell, J. , Teoh, J., Chiu, P. K., Chan, K. S., Ng, C.-F., Heggie, R. and Hawkins, N. (2019) Economic evaluation of the introduction of the Prostate Health Index as a rule-out test to avoid unnecessary biopsies in men with prostate specific antigen levels of 4-10 in Hong Kong. PLoS ONE, 14(4), e0215279. (doi: 10.1371/journal.pone.0215279) (PMID:30990840) (PMCID:PMC6467402)

Willis, S., De Corte, K., Cairns, J.A., Zia Sadique, M., Hawkins, N. , Pennington, M., Cho, G., Roberts, D.J., Miflin, G. and Grieve, R. (2019) Cost-effectiveness of alternative changes to a national blood collection service. Transfusion Medicine, 29(S1), pp. 428-51. (doi: 10.1111/tme.12537) (PMID:29767450)

Barrett, K. A., Hawkins, N. and Fan, E. (2019) Economic evaluation of venovenous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Critical Care Medicine, 47(2), pp. 186-193. (doi: 10.1097/CCM.0000000000003465) (PMID:30312186)

2018

Muston, D., Korobelnik, J.-F., Reason, T., Hawkins, N. , Chatzitheofilou, I., Ryan, F. and Kaiser, P. K. (2018) An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data. BMC Ophthalmology, 18(1), p. 340. (doi: 10.1186/s12886-018-1006-9) (PMID:30591022) (PMCID:PMC6307247)

Williams, M., Chen, J., Hart, M. G., Hunter, A., Hawkins, N. , Si, S. and Toni, F. (2018) First-line treatments for people with single or multiple brain metastases. Cochrane Database of Systematic Reviews, 9, CD013223. (doi: 10.1002/14651858.cd013223)

Best, L. M.J., Freeman, S., Sutton, A. J., Hawkins, N. , Tsochatzis, E. and Gurusamy, K. S. (2018) Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews, 9, CD013103. (doi: 10.1002/14651858.cd013103) (PMCID:PMC6513213)

Pennington, M., Grieve, R., Van der Meulen, J. and Hawkins, N. (2018) The value of external data in the extrapolation of survival data: a study using the NJR data set. Value in Health, 21(7), pp. 822-829. (doi: 10.1016/j.jval.2017.12.023) (PMID:30005754)

Wright, C. M., Boudarène, L., Ha, N. T., Wu, O. and Hawkins, N. (2018) A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries. BMC Public Health, 18, 373. (doi: 10.1186/s12889-018-5261-8) (PMID:29558894) (PMCID:PMC5859762)

Beca, J., Husereau, D., Chan, K. K.W., Hawkins, N. and Hoch, J. S. (2018) Oncology modeling for fun and profit! Key steps for busy analysts in health technology assessment. PharmacoEconomics, 36(1), pp. 7-15. (doi: 10.1007/s40273-017-0583-4) (PMID:29110141)

2017

Hawkins, N. and Grieve, R. (2017) Extrapolation of survival data in cost-effectiveness analyses. Medical Decision Making, 37(4), pp. 337-339. (doi: 10.1177/0272989X17697019) (PMID:28355938)

Saffioti, F., Gurusamy, K. S., Hawkins, N. , Toon, C. D., Tsochatzis, E., Davidson, B. R. and Thorburn, D. (2017) Pharmacological interventions for primary sclerosing cholangitis. Cochrane Database of Systematic Reviews, 3, CD011343. (doi: 10.1002/14651858.CD011343.pub2) (PMID:28417463) (PMCID:PMC6464655)

De Socio, G. V., Kimaro, G. D., Mfinanga, S., Simms, V., Kivuyo, S., Bottomley, C., Hawkins, N. , Harrison, T. S., Jaffar, S. and Guinness, L. (2017) The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies. PLoS ONE, 12(2), e0171917. (doi: 10.1371/journal.pone.0171917) (PMID:28234969) (PMCID:PMC5325220)

Hawkins, N. , Heggie, R. and Wu, O. (2017) Reliable sources? Generating, selecting, and applying evidence to inform the health benefits package. In: Glassman, A., Giedion, U. and Smith, P.C. (eds.) What's In, What's Out: Designing Benefits for Universal Health Coverage. Brookings Institution Press, pp. 235-246. ISBN 9781944691059

2016

Mealing, S., Woods, B., Hawkins, N. , Cowie, M. R., Plummer, C. J., Abraham, W. T., Beshai, J. F., Klein, H. and Sculpher, M. (2016) Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure. Heart, 102(21), pp. 1742-1749. (doi: 10.1136/heartjnl-2015-308883) (PMID:27411837)

Wu, O. , McMeekin, N. and Hawkins, N. (2016) Lost in Translation: Randomised Controlled Trial and Systematic Review Evidence of Intracoronary Versus Intravenous Abciximab in St-Elevation Myocardial Infarction. ISPOR 19th Annual European Congress, Vienna, Austria, 29 Oct - 2 Nov 2016. A639. (doi: 10.1016/j.jval.2016.09.1685)

Gurusamy, K. S., Pallari, E., Hawkins, N. , Pereira, S. P. and Davidson, B. R. (2016) Management strategies for pancreatic pseudocysts. Cochrane Database of Systematic Reviews, 4, CD011392. (doi: 10.1002/14651858.CD011392.pub2) (PMID:27075711) (PMCID:PMC6457582)

Thompson, J. C., Quigley, J. M., Halfpenny, N. J. A., Scott, D. A. and Hawkins, N. S. (2016) Importance and methods of searching for E-publications ahead of print in systematic reviews. Evidence-Based Medicine, 21(2), pp. 55-59. (doi: 10.1136/ebmed-2015-110374) (PMID:26912572)

2015

Hawkins, N. , Scott, D. A. and Woods, B. (2015) ‘Arm-based’ parameterization for network meta-analysis. Research Synthesis Methods, 7(3), pp. 306-313. (doi: 10.1002/jrsm.1187) (PMID::26610409) (PMCID:PMC5063191)

Scott, D. A., Woods, B., Thompson, J. C., Clark, J. F., Hawkins, N. , Chambers, M., Celli, B. R. and Calverley, P. (2015) Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Pulmonary Medicine, 15(1), 145. (doi: 10.1186/s12890-015-0138-4) (PMID:26559138) (PMCID:PMC4642642)

Woods, B., Hawkins, N. , Mealing, S., Sutton, A., Abraham, W.T., Beshai, J.F., Klein, H., Sculpher, M., Plummer, C.J. and Cowie, M.R. (2015) Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart, 101(22), pp. 1800-1806. (doi: 10.1136/heartjnl-2015-307634) (PMID:26269413) (PMCID:PMC4680159)

Govan, L. , Wu, O. , Xin, Y. , Hutchinson, S. J. and Hawkins, N. (2015) Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis. European Journal of Gastroenterology and Hepatology, 27(8), pp. 882-894. (doi: 10.1097/meg.0000000000000376) (PMID:25919772)

Lipton, J.H., Bryden, P., Sidhu, M.K., Huang, H., McGarry, L.J., Lustgarten, S., Mealing, S., Woods, B., Whelan, J. and Hawkins, N. (2015) Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors. Leukemia Research, 39(1), pp. 58-64. (doi: 10.1016/j.leukres.2014.10.005) (PMID:25466286)

2014

Halfpenny, N.J.A., Quigley, J.M. , Donatti, C. and Hawkins, N.S. (2014) Non-treatment specific parameter value estimates: relationship between BMI and utility. Value in Health, 17(7), A544. (doi: 10.1016/j.jval.2014.08.1757) (PMID:27201756)

Quigley, J.M. , Thompson, J.C., Halfpenny, N., Scott, D.A. and Hawkins, N.S. (2014) Riding the E-Publication wave. Value in Health, 17(7), A545. (doi: 10.1016/j.jval.2014.08.1763) (PMID:27201761)

Ortega, A., Fraga, M.D., Alegre-del-Rey, E.J., Puigventós-Latorre, F., Porta, A., Ventayol, P., Tenias, J.M., Hawkins, N.S. and Caldwell, D.M. (2014) A checklist for critical appraisal of indirect comparisons. International Journal of Clinical Practice, 68(10), pp. 1181-1189. (doi: 10.1111/ijcp.12487) (PMID:25269948)

Ismaila, A. S., Risebrough, N., Li, C., Corriveau, D., Hawkins, N. , FitzGerald, J. M. and Su, Z. (2014) COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada. Respiratory Medicine, 108(9), pp. 1292-1302. (doi: 10.1016/j.rmed.2014.06.005) (PMID:25175480)

Fletcher, C., Chuang-Stein, C., Paget, M.-A., Reid, C. and Hawkins, N. (2014) Subgroup analyses in cost-effectiveness analyses to support health technology assessments. Pharmaceutical Statistics, 13(4), pp. 265-274. (doi: 10.1002/pst.1626) (PMID:24931490)

Laws, A., Kendall, R. and Hawkins, N. (2014) A comparison of national guidelines for network meta-analysis. Value in Health, 17(5), pp. 642-654. (doi: 10.1016/j.jval.2014.06.001) (PMID:25128059)

Wang, S. and Hawkins, N. (2014) Incorporating moderators: Network meta-regression. In: Biondi-Zoccai, G. (ed.) Network Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison. Nova Science Publishers, pp. 157-170. ISBN 9781633210011

Goring, S., Hawkins, N. , Wygant, G., Roudaut, M., Townsend, R., Wood, I. and Barnett, A.H. (2014) Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis. Diabetes, Obesity and Metabolism, 16(5), pp. 433-442. (doi: 10.1111/dom.12239) (PMID:24237939)

Mealing, S. et al. (2014) The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis. Systematic Reviews, 3(1), 21. (doi: 10.1186/2046-4053-3-21) (PMID:24602249) (PMCID:PMC4015714)

Hawkins, N. (2014) Synthesizing clinical evidence for economic evaluation. In: Culyer, A. J. (ed.) Encyclopedia of Health Economics. Elsevier, pp. 382-385. ISBN 9780123756794 (doi: 10.1016/B978-0-12-375678-7.01404-8)

2012

Hawkins, N. , Richardson, G., Sutton, A. J., Cooper, N. J., Griffiths, C., Rogers, A. and Bower, P. (2012) Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach. Health Economics, 21(6), pp. 742-756. (doi: 10.1002/hec.1741) (PMID:21796723)

Reich, K., Burden, A.D., Eaton, J.N. and Hawkins, N.S. (2012) Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials. British Journal of Dermatology, 166(1), pp. 179-188. (doi: 10.1111/j.1365-2133.2011.10583.x) (PMID:21910698)

2011

Hawkins, N. and Scott, D. A. (2011) Reimbursement and value-based pricing: stratified cost-effectiveness analysis may not be the last word. Health Economics, 20(6), pp. 688-698. (doi: 10.1002/hec.1625) (PMID:20568075)

Hoaglin, D. C. et al. (2011) Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2. Value in Health, 14(4), pp. 429-437. (doi: 10.1016/j.jval.2011.01.011) (PMID:21669367)

Jansen, J. P., Fleurence, R., Devine, B., Itzler, R., Barrett, A., Hawkins, N. , Lee, K., Boersma, C., Annemans, L. and Cappelleri, J. C. (2011) Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR task force on indirect treatment comparisons good research practices: part 1. Value in Health, 14(4), pp. 417-428. (doi: 10.1016/j.jval.2011.04.002) (PMID:21669366)

Gross, J. L., Kramer, C. K., Leitão, C. B., Hawkins, N. , Viana, L. V., Schaan, B. D., Pinto, L. C., Rodrigues, T. C. and Azevedo, M. J. (2011) Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. Annals of Internal Medicine, 154(10), pp. 672-679. (doi: 10.7326/0003-4819-154-10-201105170-00007) (PMID:21576535)

Woods, B., Veenstra, D. and Hawkins, N. (2011) Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment. Value in Health, 14(8), pp. 989-1001. (doi: 10.1016/j.jval.2011.05.048) (PMID:22152167)

This list was generated on Wed Dec 18 15:13:18 2024 GMT.

Jump to: Articles | Book Sections | Conference or Workshop Item